Syntax Advisors’s CVS Health CVS Stock Holding History

Syntax Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$696K	Buy	9,969 +890	+10%	+$63.1K	0.61%	10
2023 Q2	$628K	Buy	9,079 +273	+3%	+$19.4K	0.51%	10
2023 Q1	$654K	Buy	8,806 +2,066	+31%	+$173K	0.5%	11
2022 Q4	$628K	Sell	6,740 -387	-5%	-$37.3K	0.52%	11
2022 Q3	$680K	Sell	7,127 -184	-3%	-$18.2K	0.58%	10
2022 Q2	$677K	Buy	7,311 +1,027	+16%	+$100K	0.57%	9
2022 Q1	$636K	Sell	6,284 -1,166	-16%	-$122K	0.53%	11
2021 Q4	$769K	Buy	+7,450	New	+$688K	0.57%	11

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Syntax Advisors's CVS Position: Q3 2023 in Review

Syntax Advisors increased its CVS Health (CVS) stake by 9.8% in Q3 2023, buying an estimated $63.1K and bringing the position to 9,969 shares worth $696K. The position accounts for 0.61% of the portfolio, ranked #10.

Syntax Advisors first reported a position in CVS in Q4 2021 and has held it in 8 quarters since. The position peaked at $769K in Q4 2021. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

Syntax Advisors held 9,969 shares of CVS Health worth $696K as of Q3 2023.
Syntax Advisors bought 890 CVS Health shares in Q3 2023, an estimated $63.1K.
CVS Health made up 0.61% of Syntax Advisors's portfolio in Q3 2023, its #10 holding.
Syntax Advisors first reported a position in CVS Health in Q4 2021 and has held it in 8 quarters since.
Syntax Advisors's CVS Health position peaked at $769K in Q4 2021.
2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.